[1]BRAY F,FERLAY J,SOERJOMA I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[2]KRUGER S,ILMER M,KOBOLD S,et al.Advances in cancer immunotherapy 2019-latest trends[J].J Exp Clin Cancer Res,2019,38(1):268.
[3]WONG SL.Lymph node evaluation in colon cancer:assessing the link between quality indicators and quality[J].Jama,2011,306(10):1139-1141.
[4]ZHUO CH,XU Y,YING MG,et al.FOXP3+ Tregs:heterogeneous phenotypes and conflicting impacts on survival outcomes in patients with colorectal cancer[J].Immunol Res,2015,61(3):338-347.
[5]HE WZ,XIE QK,HU WM,et al.An increased number of negative lymph nodes is associated with a higher immune response and longer survival in colon cancer patients[J].Cancer Management and Research,2018,10:1597-1604.
[6]QUAN Q,ZHU MS,LIU SS,et al.Positive impact of the negative lymph node count on the survival rate of stage III colon cancer with pN1 and right-side disease[J].Journal of Cancer,2019,10(4):1052-1059.
[7]KUO YH,YOU JF,HUNG HY,et al.Number of negative lymph nodes with a positive impact on survival of stage III colon cancer; a retrospective observation study for right side and left side colon[J].BMC Cancer,2022,22(1):126.
[8]NAKAMURA Y,FUJISAWA Y,OKIYAMA N,et al.Surgical damage to the lymphatic system promotes tumor growth via impaired adaptive immune response[J].J Dermatol Sci,2018,90(1):46-51.
[9]BACZYNSKA D,WIETRZYK J,MADEJ J,et al.The tumorigenic potential of human CX-1 colon adenocarcinoma cells depends on carcinoembryonic antigen(CEACAM5) expression[J].Cell Mol Biol Lett,2003,8(2):471-486.
[10]TIAN Y,WEN HX,WU HT,et al.The relationship between preoperative routine blood tests and postoperative tumor characteristics in patients with colorectal cancer[J].Acta Academiae Medicinae Xuzhou,2021,41(2):113-118.
[11]敬秀平,刘珊,宋小平.结直肠癌患者的血清癌胚抗原、甲胎蛋白和糖类抗原19-9水平及临床意义[J].癌症进展,2020,18(12):1244-1247.
JING XP,LIU S,SONG XP.Expression of serum carcinoembryonic antigen,alpha-fetoprotein and carbohydrate antigen 19-9 in patients with colorectal cancer and its clinical significance[J].Oncology Progress,2020,18(12):1244-1247.
[12]程煌荣,郑勇斌.结直肠癌患者肿瘤静脉血CTCs和CEA mRNA水平对异时性肝转移的预测价值[J].现代肿瘤医学,2021,29(2):263-266.
CHENG HR,ZHENG YB.Detection of CTCs and CEA mRNA levels in tumor venous blood of patients with colorectal cancer for predicting metachronous liver metastasis[J].Modern Oncology,2021,29(2):263-266.
[13]MIAO H,RUAN S,SHEN M.VEGF-C in rectal cancer tissues promotes tumor invasion and metastasis[J].J BUON,2018,23(1):42-47.
[14]TACCONI C,CORREALE C,GANDELLI A,et al.Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion[J].Gastroenterology,2015,148(7):1438-1451.
[15]BI MM,SHANG B,WANG Z,et al.Expression of CXCR4 and VEGF-C is correlated with lymph node metastasis in non-small cell lung cancer[J].Thoracic Cancer,2017,8(6):634-641.
[16]NAKAMURA H,ISHIGURO K,MORI T.Different immune functions of peripheral blood,regional lymph node,and tumor infiltrating lymphocytes in lung cancer patients[J].Cancer,1988,62(12):2489-2497.
[17]CHEN YY,GE JY,MA D,et al.Immune-activated regional lymph nodes predict favorable survival in early-stage triple-negative breast cancer[J].Front Oncol,2020,10:570981.
[18]VERONESI U,MARUBINI E,MARIANI L,et al.The dissection of internal mammary nodes does not improve the survival of breast cancer patients.30-year results of a randomised trial [J].Eur J Cancer,1999,35(9):1320-1325.
[19]VAN PUL KM,FRANSEN MF,VANDE VR,et al.Immunotherapy goes local:The central role of lymph nodes in driving tumor infiltration and efficacy[J].Front Immunol,2021,12:643291.